• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,102.83 299.93
( 0.39%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
72,454.13 1,204.07
(1.69%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Kovai Medical Center & Hospital Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
523323
INE177F01017
1205.904936
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
KOVAI
26.11
6383.27
EPS(TTM)
Face Value()
Div & Yield %
223.46
10
0.26
 

Rain Industries reports turnaround Q1 performance
May 09,2026
Revenue from operations increased by 20% YoY to Rs 4,520.73 crore during the quarter.

Adjusted EBITDA rose by 64.65% to Rs 714.9 crore in Q1 2026 from Rs 434.2 crore recorded in Q1 2025. The adjusted EBITDA margin in Q1 2026 was 15.8% as against 11.5% in Q1 2025.

The company posted a pre-tax profit of Rs 255.78 crore in Q1 2026 as compared with a pre-tax loss of Rs 25.95 crore recorded in Q1 2025.

In its latest business outlook, Rain Industries said it is focusing on strengthening its business model across the Carbon, Advanced Materials, and Cement segments. The company continues to work on developing alternative raw material sources to improve capacity utilization and mitigate supply disruptions in the Middle East. It is also leveraging its in-house expertise in distillation and calcination to develop raw materials for emerging markets in BAM and ESM, while actively monitoring debt markets to optimize interest costs.

Rain Industries is the holding company with subsidiaries engaged in the manufacturing of cement, calcined petroleum coke (CPC), coal tar pitch (CTP), and downstream products, including resins, modifiers, and superplasticizers.

The scrip advanced 6.80% to end at Rs 143.65 on Friday, 8 May 2026.